Indian Journal of Animal Research

Indian Journal of Animal Research cover
Volume 56 · Issue 1 · 2020/12/29

Chemotherapeutic Effects of Docetaxel and Gene Expression of Epidermal Growth Factor Receptor During Regression of Mammary Tumours in Canines

Prachi Upadhyay
N.S. Jadon
Priyanka Pandey
Jyotsana Bhatt
Ramanpreet Singh Sandhu
Deepti Bodh
Manjul Kandpal
Sara Kaushal
85 Views

Submitted

2020/06/16

First Online

2020/12/29

doi

10.18805/IJAR.B-4223

Cite article - Prachi Upadhyay, N.S. Jadon, Priyanka Pandey, Jyotsana Bhatt, Ramanpreet Singh Sandhu, Deepti Bodh, Manjul Kandpal, Sara Kaushal. (2020). Chemotherapeutic Effects of Docetaxel and Gene Expression of Epidermal Growth Factor Receptor During Regression of Mammary Tumours in Canines. Indian Journal of Animal Research. 56(1): 72–77. doi: 10.18805/IJAR.B-4223

Abstract

Background: In this study the chemotherapeutic effects of docetaxel and gene expression of epidermal growth factor receptor (EGFR) during regression of mammary tumour in canines were evaluated.

Methods: Sixteen dogs suffering from canine mammary tumour were randomly divided into two groups viz . I and II and subjected to Docetaxel @ 30mg/m 2 weekly, four consecutive cycles, (Group I) and surgical excision of tumour followed by chemotherapy with Docetaxel @ 30mg/m 2 weekly, four consecutive cycles, (Group II). The therapeutic efficacy was assessed by clinical, radiological, ultrasonography, haemato-biochemical and histopathological evaluation including gene expression profiling of EGFR using Real-time PCR analysis.

Result: On the basis of the above parameters studied it was concluded that combination of surgery and chemotherapy using docetaxel is an effective treatment for the regression of mammary tumour and can be used safely by the field veterinarian. Real-time PCR analysis also revealed down-regulation of EGFR gene in group II.

Acknowledgement

true

References

  1. Benavente, M.A., Bianchi, C.P., Aba, M.A. (2016). Canine mammary tumours: risk factors, prognosis and treatments. Journal of Veterinary Advances. 6(8): 1291-1300. Brar, R.S., Sandhu, H.S., Singh, A. (2000). Veterinary clinical diagnosis by laboratory methods. Kalyani publications. New Delhi :47-159. Brodey, R., GoldSchmidt, M.H., Roszel, J.R. (1983). Canine mammary gland neoplasm. Journal of the American Animal Hospital Association. 19: 61-66. Gupta, N. and Tiwari, S.K. (2008). Study on incidence, histopathological features and surgical management of neoplasms in canine. Veterinary World. 2(10): 292-39. Khan, G.J., Thorat, M.G., Raulkar, R.V., Upadhye, S.V., Jadhao, P.T., Chepte, S.D. Deshmukh, S.G. (2017). Surgico-chemotherapeutic management of mammary tumoin canine. International Journal of Science. 5(6): 3154-3159. Luna, L.G. (1992). Manual of histology stainig methods of the armed forces institute of pathology, III rd. Hematology. 31: 411-413. Motalleb, G., Pourrahmat, E., Rashki, A., Moghadam, A.Y., Mazaheri, M., Jahantigh, M., Sabagh, K., Sanadgol, N., Najafi, S., Talaee, R. (2014). Epidermal growth factor receptor gene expression evaluation in colorectal cancer patients. Indian Journal of Cancer. 51(3): 358. Nyman, H.T., Nielsen, O.L., McEvoy, F.J., Lee, M., Martinussen, T., Hellmén, E., Kristensen, A.T. (2006). Comparison of B-mode and Doppler ultrasonographic findings with histologic features of benign and malignant mammary tumours in dogs. American Journal of Veterinary Research. 67(6): 985-991. Puisset, F., Alexandre, J., Treluyer, J.M., Raoul, V., Roche, H., Goldwasser, F.,Chatelut, E. (2007). Clinical pharmacodynamic factors in docetaxel toxicity. British Journal of Cancer. 97(3): 290. Queiroga, F.L., PerezAlenza, M.D., GonzálezGil, A., Silván, G., Peña, L., Illera, J.C. (2017). Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications. Veterinary and Comparative Oncology. 15(2): 383-390. Simon, D., Schoenrock, D., Baumgärtner, W., Nolte, I. (2006). Postoperative adjuvant treatment of invasive malignant mammary gland tumours in dogs with doxorubicin and docetaxel. Journal of Veterinary Internal Medicine. 20(5): 1184-1190. Snedecor, G.W. and Cochran, W.G. (1994). Calcutta, India: Statistical methods (eighth edition). Oxford andIBH Publishing Co:79-89. Soler, M., Dominguez, E., Lucas, X., Novellas, R., Gomes-Coelho, K.V., Espada, Y., Agut, A. (2016). Comparison between ultrasonographic findings of benign and malignant canine mammary gland tumours using B-mode, colour Doppler, power Doppler and spectral Doppler. Research in Veterinary Science. 107: 141-146. Valabrega, G., Montemurro, F., Aglietta, M. (2007). Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer. Annals of Oncology. 18(6): 977-984. Verma, A.K., Jadon, N.S., Pandey, P., Tiwari, A.K. (2014). Gross, histopathological and electronmicroscopic studies of canine mammary gland tumour treated with NS1 gene of canine parvo virus. Indian Journal of Animal Sciences. 84(4): 373-378. Yoshimura, H., Michishita, M., Ohkusu-Tsukada, K., Takahashi, K. (2011). Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumours. Veterinary Pathology. 48(1): 313-321.
EDITORIAL BOARD

Guided by Experienced Academic Leadership

Distinguished scholars and subject experts committed to editorial excellence, scientific integrity and rigorous peer review.

View Full Board
Yashpal Singh Malik
Chief Editor

Yashpal Singh Malik

Deputy Director General (Agricultural Education)Indian Council of Agricultural Research, Headquarters, New Delhi , India

L.D. Singla
Associate chief editor

L.D. Singla

Professor and HeadAbhilashi University, Chachyot, Himachal Pradesh, India

Vilas G. Atkare
Editor

Vilas G. Atkare

DeanDr. Panjabrao Deshmukh Krishi Vidyapeeth, Akola, Krishi Nagar, Maharashtra, India

S. Maya
Editor

S. Maya

Associate Dean and Professor & HeadKerala Veterinary and Animal Sciences University, Mannuthy, Thrissur, Kerala, India